Opentrons Labworks, Inc. is an innovative biotechnology and laboratory automation company headquartered in Long Island City, New York, United States. Founded in 2014, Opentrons is dedicated to democratizing access to advanced lab robotics, making powerful automation tools affordable, intuitive, and widely usable for scientists in research, healthcare, and industry.
At its core, Opentrons develops liquid-handling robots and automation solutions designed to streamline repetitive laboratory workflows—such as pipetting, sample preparation, and high-throughput assays—so that researchers can focus on discovery rather than manual tasks. Its flagship products include the OT-2 and the next-generation Opentrons Flex robots, which combine accessible hardware with flexible software and an extensive protocol library to support diverse experimental needs.
Driven by its mission to remove barriers to automation, Opentrons also offers a growing Protocol Library and AI-enabled tools that provide verified, plug-and-play workflows for common applications in genomics, proteomics, cell biology, synthetic biology, and more—empowering labs of all sizes to scale their research efficiently.
Opentrons has achieved strong global adoption, with its automation systems used by universities, biopharmaceutical companies, and research institutions worldwide. The company has raised substantial funding, attained unicorn status, and continues expanding its ecosystem to deliver cost-effective, intelligent automation solutions that accelerate scientific innovation.